Vogelsang M, Broede-Sitz A, Schäfer E, Zerkowski H R, Brodde O E
Biochemical Research Laboratory, Medizinische Klinik and Poliklinik, University of Essen, Germany.
J Cardiovasc Pharmacol. 1994 Feb;23(2):344-7.
To study signal transduction pathways of endothelin (ET) in human heart, we assessed, in isolated human right atria, the effects of ET-1 and ET-3 on inositol phosphate (IP) formation and on the adenylate cyclase/cyclic AMP system. In right atrial slices, ET-1 (10(-10)-10(-6)M) concentration-dependently increased [3H]IP accumulation and decreased 10-microM isoprenaline-induced or 1-microM forskolin-induced increases in cyclic AMP content. ET-3 was approximately 100 times less potent. The cyclic AMP-decreasing effect of ET-1 (10(-11)-10(-6)M) could also be demonstrated directly in adenylate cyclase assays in right atrial membranes; again, ET-3 was approximately 100 times less potent. We conclude that in human right atrium, ETA receptors couple to two different signal-transduction pathways: IP formation and inhibition of adenylate cyclase.
为研究内皮素(ET)在人心脏中的信号转导途径,我们在离体的人右心房中评估了ET-1和ET-3对肌醇磷酸(IP)生成以及对腺苷酸环化酶/环磷酸腺苷(cAMP)系统的影响。在右心房切片中,ET-1(10⁻¹⁰ - 10⁻⁶M)浓度依赖性地增加[³H]IP积累,并降低10μM异丙肾上腺素或1μM福斯高林诱导的cAMP含量增加。ET-3的效力约低100倍。ET-1(10⁻¹¹ - 10⁻⁶M)降低cAMP的作用也可在右心房膜的腺苷酸环化酶测定中直接证明;同样,ET-3的效力约低100倍。我们得出结论,在人右心房中,ETA受体与两种不同的信号转导途径偶联:IP生成和腺苷酸环化酶抑制。